Healix

Dalbavancin: A Nationwide Outpatient Experience in Physician Office Infusion Centers (POICs)

Authors:
Lucinda J. Van Anglen, PharmD -Healix Infusion Therapy, Inc., Sugar Land, TX
Robin H. Dretler, MD – Infectious Disease Specialists of Atlanta, Atlanta, GA
Quyen Luu, MD – Quyen Luu, MD, Macon, GA
Ramesh V. Nathan, MD, FIDSA- Mazur, Statner, Dutta, Nathan, PC, Thousand Oaks, CA
Barry Statner, MD CM, FRCPC, FIDSA – Mazur, Statner, Dutta, Nathan, PC, Thousand Oaks, CA
Fernando S. Alvarado, MD – 5Infectious Disease Consultants, Altamonte Springs, FL

View Poster View Abstract

View All

Phase II and Phase III Studies

Healix regularly and actively supports Phase II and Phase III clinical trials in each of our specialty areas, including active studies in Multiple Sclerosis and Intestinal Bowel Disease.

For information on partnering with Healix on a study, please contact us.

FacebookTwitterLinkedInarrow1arcsearchiconowdtnotfound